Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT03218137
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT03218137
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT03218137. Allocation not applicable; no masking; primary purpose diagnostic. Start 2017-02-13 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions
- Condition
- Premature Ventricular Contraction (PVC)
- Intervention (Drug)
- Adenosine
- Lead sponsor
- Weill Medical College of Cornell University
Record details
- Record id
cardio:ct-nct03218137- Content hash
65839041fbd4d26e363b270596a53181b3340c53f0a38485867fec95696367ac